Theranos | GenomeWeb

Theranos

Second Failure

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

Investors in Theranos may lose out and some are filing lawsuits, the Wall Street Journal reports.

Overwhelming Response

The Wall Street Journal recounts how Theranos responded when Tyler Shultz turned whistleblower.

So Many Voided

In its lawsuit papers, Walgreens says Theranos voided more than 11 percent of test reports sent to Walgreens customers, according to the Wall Street Journal.

Pharmacy company Walgreens sues its former partner for $140 million in damages, according to the Wall Street Journal.

Then Again, No

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

Facing CMS sanctions, lab industry insiders ponder the firm's options in seeking to launch a Zika virus assay with emergency use authorization on its upcoming miniLab platform.

Theranos CEO Elizabeth Holmes speaks at the AACC 2016 meeting

At the American Association for Clinical Chemistry meeting, Theranos CEO Elizabeth Holmes said her company is working on third-party review and publications of the firm's technologies and tests.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.